New diabetes clinical trial: Protecting Against Lenacapavir Misinformation With Young Women in Gauteng, South Africa ( PROTECT-L)

Published on: 2026-04-09T04:00:00Z
Conditions: Misinformation; Lenacapavir
Interventions: Behavioral: Diabetes information; Behavioral: Enhanced inoculation message
Sponsors: University of Pennsylvania; Health Economics and Epidemiology Research Office, University of the Witwatersrand; University of Cape Town
Not yet recruiting
https://ift.tt/kouqIfp